Injectables Segment to Dominate Middle East & Africa Hypertrophic and Keloid Scar Treatment Market during 2018–2027

According to a new market research study on “Middle East & Africa Hypertrophic and Keloid Scar Treatment Market to 2027 – COVID-19 Impact and Analysis and Forecast by Scar Type, Product Type, and End User,” is expected to reach US$ 280.23 million by 2027 from US$ 148.07 million in 2020. The market is estimated to grow at a CAGR of 9.5% from 2020 to 2027. The report provides trends prevailing in the Middle East & Africa hypertrophic and keloid scar treatment market along with the drivers and restraints pertaining to the market growth. Benefits of laser treatment is the major factor driving the growth of the Middle East & Africa hypertrophic and keloid scar treatment market. However, unavailability of universal treatment due to huge costs, side effects, and scanty awareness may hinder the growth of Middle East & Africa hypertrophic and keloid scar treatment market.     

Africa has reported 2,867,078 cases as of early January 2021. The number of COVID-19 cases has been increasing in South Africa (1,113,349), Iran (1,249,507), and Turkey (2,255,607). Economic uncertainties and ongoing conflicts are worsening the situation in the region. For instance, countries such as Syria, Libya, and Yemen are experiencing violent conflict and cannot complete any public health measures. Iran was in a deep economic collapse due to the US sanctions. Till October 2020, there was a higher incidence of COVID-19 in Egypt and the Republic of South Africa than in the general picture in Africa. However, the level is low as compared to the US, the UK, and Italy. The Middle East countries have registered a growth in the number of COVID-19 cases in the last few days, with the UAE registering 106,229 cases, Saudi Arabia reporting 339,267, and South Africa indicating 692,471 confirmed cases. However, the hypertrophic and keloid scar treatment market in this pandemic is declining due to the reduced demand for dermatology treatments. The countries are mainly focused on treating COVID-19 patients, and hence, the appointments for the hypertrophic and keloid scar treatment are postponed.

The market for hypertrophic and keloid scar treatment market is segmented into scar type, product type, end user, and country. Based on scar type, the hypertrophic and keloid scar treatment market is segmented into hypertrophic and keloid. The hypertrophic segment held the largest share of the market in 2019. Based on product type, the hypertrophic and keloid scar treatment market is segmented into laser products, topical products, injectables, and other products. The injectables segment held the largest share of the market in 2019. Based on topical products, the market is segmented into gels, silicone sheets, creams, other. Based on laser market is segmented into CO2, pulse-dyed, other. Based on end user, the hypertrophic and keloid scar treatment market is segmented into hospitals, clinics, and homecare. The hospitals segment held the largest share of the market in 2019. Based on country, the market is segmented into the UAE, Saudi Arabia, South Africa, and rest of Middle East & Africa. South Africa held the largest share of the market in 2019.

Alliance Pharma PLC, Mölnlycke Health Care AB., Smith & Nephew, Newmedical Technology Inc., Sonoma Pharmaceuticals, Inc, Suneva Medical, HRA Pharma and Perrigo Company plc are among the leading companies in the Middle East & Africa hypertrophic and keloid scar treatment market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2019, Merz, a global leader in aesthetics and neurotoxins, and Laboratoire HRA Pharma SAS, a fast-growing, creative global consumer health business, today announced that they have signed an asset purchase agreement under which HRA Pharma will acquire global rights to the Mederma brand, including products across scar treatment, stretch marks and skincare categories.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com